Key result
Xuefu Zhuyu granule improved chest stuffiness and heartache syndrome in stable angina patients with depressive symptoms.
Why the study?
Depressive symptoms are prevalent in coronary heart disease and reduce quality of life, but psychotropic drugs carry warnings about side effects, creating an urgent need for safer alternatives.
Does Xuefu Zhuyu granule improve angina pectoris-specific health status in patients with stable angina pectoris and depressive symptoms?
Does Xuefu Zhuyu granule improve angina pectoris-specific health status in patients with stable angina pectoris and depressive symptoms?
Xuefu Zhuyu granule may improve angina-specific health status and serum ATP levels in patients with stable angina and depressive symptoms.
Answers are grounded in this paper and cite their sources.
May support adjunctive use in stable angina with depression; leaves open confirmation by randomized trials.
Depressive symptoms have been found to be highly prevalent among patients with coronary heart disease (CHD) and seriously affect the patients’ quality of life. However, most psychotropic drugs have warnings about potential side effects. Accordingly, safer effective alternatives are urgently demanded. Angina pectoris of CHD is considered as “chest stuffiness and heartache syndrome” in traditional Chinese medicine, with the major syndrome type named Qi stagnation and blood stasis. Qi-regulating and blood circulation-promoting therapy has increasingly shown unique advantages in CHD patients. This study investigated the efficacy of Xuefu Zhuyu decoction, a representative prescription of Qi-regulating and blood circulation-promoting therapy, on angina pectoris patients with depressive symptoms. Depressive symptoms were stratified at baseline in 30 patients with stable angina pectoris who participated in both baseline and 12-week follow-up studies. After performing a stratified analysis, the angina pectoris-specific health status and traditional Chinese medicine “chest stuffiness and heartache syndrome” were evaluated by self-reports using the associated questionnaire scales, respectively. We measured serum concentrations of serotonin, brain-derived neurotrophic factor, and ATP, which are associated with the development of depression. We found that the Xuefu Zhuyu granule significantly improved the angina pectoris-specific health status in patients after 12 weeks of treatment; specifically, it had a better curative effect on patients with depressive symptoms. Xuefu Zhuyu granule also significantly improved the chest stuffiness and heartache syndrome in patients with depressive symptoms (efficacy index is 61.24%, P < 0.05 versus baseline). Interestingly, Xuefu Zhuyu granule has been found to be more susceptible to improving ATP levels in patients with depressive symptoms, indicating that the improvement in serum ATP levels might account for the better efficacy of Xuefu Zhuyu granule in patients with depressive symptoms. Our data provide prospective evidence that Xuefu Zhuyu granule improves angina pectoris-specific health status through regulating Qi and promoting blood circulation. This trial is registered with ChiCTR-IOR-15006989.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2021) studied Stable angina pectoris with depressive symptoms (n=30). Xuefu Zhuyu granule vs. Baseline was evaluated on Chest stuffiness and heartache syndrome (p=< 0.05). Xuefu Zhuyu granule improved chest stuffiness and heartache syndrome in stable angina patients with depressive symptoms.
Synapse has enriched 10 related papers. Consider them for comparative context: